These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20488919)

  • 21. Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status).
    Smolderen KG; Buchanan DM; Gosch K; Whooley M; Chan PS; Vaccarino V; Parashar S; Shah AJ; Ho PM; Spertus JA
    Circulation; 2017 May; 135(18):1681-1689. PubMed ID: 28209727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and prognostic consequence of gastrointestinal bleeding in patients with ST-segment elevation myocardial infarction.
    Kikkert WJ; Hassell MECJ; Delewi R; van der Laan MH; Baan J; Vis MM; Koch KT; de Winter RJ; Piek JJ; Tijssen JGP; Henriques JPS
    Int J Cardiol; 2015 Apr; 184():128-134. PubMed ID: 25703420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR).
    Xian Y; Chen AY; Thomas L; Roe MT; Subherwal S; Cannon CP; Pollack CV; Fonarow GC; Kosiborod M; Peterson ED; Alexander KP
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):236-43. PubMed ID: 24594548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4.
    Peterson ED; Pollack CV; Roe MT; Parsons LS; Littrell KA; Canto JG; Barron HV;
    J Am Coll Cardiol; 2003 Jul; 42(1):45-53. PubMed ID: 12849658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE).
    Fox KA; Goodman SG; Klein W; Brieger D; Steg PG; Dabbous O; Avezum A
    Eur Heart J; 2002 Aug; 23(15):1177-89. PubMed ID: 12127920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of nonagenarians with acute myocardial infarction who undergo percutaneous coronary intervention.
    Nishihira K; Watanabe N; Kuriyama N; Shibata Y
    Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):488-495. PubMed ID: 32324045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.
    Prabhakaran D; Yusuf S; Mehta S; Pogue J; Avezum A; Budaj A; Cerumzynski L; Flather M; Fox K; Hunt D; Lisheng L; Keltai M; Parkhomenko A; Pais P; Reddy S; Ruda M; Hiquing T; Jun Z
    Indian Heart J; 2005; 57(3):217-25. PubMed ID: 16196178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR.
    Anderson ML; Peterson ED; Peng SA; Wang TY; Ohman EM; Bhatt DL; Saucedo JF; Roe MT
    Circ Cardiovasc Qual Outcomes; 2013 Nov; 6(6):708-15. PubMed ID: 24221834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.
    Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Patel D; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28855222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, Predictors, and Outcomes of Hospital-Acquired Anemia.
    Makam AN; Nguyen OK; Clark C; Halm EA
    J Hosp Med; 2017 May; 12(5):317-322. PubMed ID: 28459899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discharge heart rate and mortality after acute myocardial infarction.
    Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
    Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.
    Wong SC; Sleeper LA; Monrad ES; Menegus MA; Palazzo A; Dzavik V; Jacobs A; Jiang X; Hochman JS;
    J Am Coll Cardiol; 2001 Nov; 38(5):1395-401. PubMed ID: 11691514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand.
    Srichaiveth B; Ruengsakulrach P; Visudharom K; Sanguanwong S; Tangsubutr W; Insamian P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():65-73. PubMed ID: 18431888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood transfusion, bleeding, anemia, and survival in patients with acute myocardial infarction: FAST-MI registry.
    Ducrocq G; Puymirat E; Steg PG; Henry P; Martelet M; Karam C; Schiele F; Simon T; Danchin N
    Am Heart J; 2015 Oct; 170(4):726-734.e2. PubMed ID: 26386796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial.
    Wester A; Attar R; Mohammad MA; Andell P; Hofmann R; Jensen J; Szummer K; Erlinge D; Koul S
    J Am Heart Assoc; 2019 Aug; 8(16):e012741. PubMed ID: 31387441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.
    Nathan AS; Xiang Q; Wojdyla D; Khatana SAM; Dayoub EJ; Wadhera RK; Bhatt DL; Kolansky DM; Kirtane AJ; Rao SV; Yeh RW; Groeneveld PW; Wang TY; Giri J
    JAMA Cardiol; 2020 Jul; 5(7):765-772. PubMed ID: 32347890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction.
    Thompson LE; Masoudi FA; Gosch KL; Peterson PN; Jones PG; Salisbury AC; Kosiborod M; Daugherty SL
    Clin Cardiol; 2017 Dec; 40(12):1279-1284. PubMed ID: 29247532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
    Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
    J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.